Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Adverse Reactions in a Clinical Trial with Empagliflozin (Add-On Combination Therapy with Metformin HCl and Sulfonylurea) for Glycemic Control in Adults with Type 2 Diabetes Mellitus In a 24-week placebo-controlled trial of empagliflozin 10 mg or 25 mg administered once daily added to metformin HCl and sulfonylurea, adverse reactions reported in 5% of empagliflozin-treated patients and more commonly than in placebo-treated patients are presented in Table 1 (see also Table 4)
These medications fundamentally alter pancreatic islet cell function in a glucose-dependent manner, which provides both therapeutic efficacy and an important safety advantage over older diabetes medications
doi:10.1210/en.2013-1934 Nauck MA, Niedereichholz U, Ettler R, et al
.png)
They tend to also be Trojan horses for, um, you know, chemicals that you won't necessarily find on the nutrition facts label
US$ 25.74
US$ 21.17
US$ 26.92
US$ 21.27
US$ 21.69
US$ 28.01
US$ 29.86
US$ 23.77
